Disease_1
stringlengths 4
61
| Disease_2
stringlengths 4
61
| Similarity_Score
stringclasses 78
values |
|---|---|---|
Drug-Induced Abnormalities
|
Waardenburg Syndrome
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Spinal Muscular Atrophies of Childhood
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Werner Syndrome
|
0.22612546428933034
|
Drug-Induced Abnormalities
|
Wiskott-Aldrich Syndrome
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Wolff-Parkinson-White Syndrome
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Wolfram Syndrome
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Xeroderma Pigmentosum
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Hydrops Fetalis
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Gouty Arthritis
|
0.12229063423583264
|
Drug-Induced Abnormalities
|
Zellweger Syndrome
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Cholesterol Ester Storage Disease
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Wolman Disease
|
0.22612546428933034
|
Drug-Induced Abnormalities
|
Inborn Errors Fructose Metabolism
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
6-Diphosphatase Deficiency Fructose-1
|
0.12229063423583264
|
Drug-Induced Abnormalities
|
Inborn Errors Pyruvate Metabolism
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Pyruvate Carboxylase Deficiency Disease
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Pyruvate Dehydrogenase Complex Deficiency Disease
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Hereditary Sensory and Motor Neuropathy
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Hereditary Optic Atrophies
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Hereditary Spastic Paraplegia
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Inborn Errors Renal Tubular Transport
|
0.22612546428933034
|
Drug-Induced Abnormalities
|
Rett Syndrome
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Choledochal Cyst
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Congenital Cystic Adenomatoid Malformation of Lung
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Respiratory System Abnormalities
|
0.4373356273919856
|
Drug-Induced Abnormalities
|
Diffuse Palmoplantar Keratoderma
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Aniridia
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Hereditary Eye Diseases
|
0.22612546428933034
|
Drug-Induced Abnormalities
|
Retinal Dysplasia
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Choroideremia
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Gyrate Atrophy
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Arachnoid Cysts
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Gerstmann-Straussler-Scheinker Disease
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Epidermolysis Bullosa Acquisita
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Epidermolysis Bullosa Dystrophica
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Junctional Epidermolysis Bullosa
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Epidermolysis Bullosa Simplex
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Sjogren-Larsson Syndrome
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Ichthyosis Vulgaris
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Congenital Ichthyosiform Erythroderma
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
X-Linked Ichthyosis
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Oculocutaneous Albinism
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Piebaldism
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Ocular Albinism
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Spinal Dysraphism
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Spina Bifida Occulta
|
0.310198271667516
|
Drug-Induced Abnormalities
|
Spina Bifida Cystica
|
0.310198271667516
|
Drug-Induced Abnormalities
|
Holoprosencephaly
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Lysosomal Storage Diseases
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Benign Familial Pemphigus
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Severe Combined Immunodeficiency
|
0.22612546428933034
|
Drug-Induced Abnormalities
|
Neurofibromatosis 2
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Mucopolysaccharidosis II
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
GM1 Gangliosidosis
|
0.06323372317637754
|
Drug-Induced Abnormalities
|
Mucopolysaccharidosis VII
|
0.12229063423583264
|
Drug-Induced Abnormalities
|
Blepharophimosis
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Proteus Syndrome
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Alagille Syndrome
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Caroli Disease
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Li-Fraumeni Syndrome
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
POEMS Syndrome
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Autosomal Dominant Polycystic Kidney
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Maternal Phenylketonuria
|
0.12229063423583264
|
Drug-Induced Abnormalities
|
Autosomal Recessive Polycystic Kidney
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
alpha-Thalassemia
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
beta-Thalassemia
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Erythropoietic Porphyria
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Hepatic Porphyrias
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Acute Intermittent Porphyria
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Porphyria Cutanea Tarda
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Hepatoerythropoietic Porphyria
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Angelman Syndrome
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
MELAS Syndrome
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
MERRF Syndrome
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Neurofibromatoses
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Kallmann Syndrome
|
0.310198271667516
|
Drug-Induced Abnormalities
|
Epidermolytic Hyperkeratosis
|
0.310198271667516
|
Drug-Induced Abnormalities
|
Lamellar Ichthyosis
|
0.310198271667516
|
Drug-Induced Abnormalities
|
Porokeratosis
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Hyperandrogenism
|
0.310198271667516
|
Drug-Induced Abnormalities
|
WAGR Syndrome
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Polydactyly
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Canavan Disease
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Machado-Joseph Disease
|
0.12229063423583264
|
Drug-Induced Abnormalities
|
Congenital Limb Deformities
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Odontodysplasia
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Gonadoblastoma
|
0.28232930875488305
|
Drug-Induced Abnormalities
|
Leukocyte-Adhesion Deficiency Syndrome
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Cardiovascular Abnormalities
|
0.4373356273919856
|
Drug-Induced Abnormalities
|
Pulmonary Atresia
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Hypoplastic Left Heart Syndrome
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Stomatognathic System Abnormalities
|
0.4373356273919856
|
Drug-Induced Abnormalities
|
Multiple Endocrine Neoplasia Type 1
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Tricuspid Atresia
|
0.3430264696222015
|
Drug-Induced Abnormalities
|
Multiple Endocrine Neoplasia Type 2a
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Multiple Endocrine Neoplasia Type 2b
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Peroxisomal Disorders
|
0.18766904849475052
|
Drug-Induced Abnormalities
|
Rhizomelic Chondrodysplasia Punctata
|
0.15364182357778045
|
Drug-Induced Abnormalities
|
Williams Syndrome
|
0.38355214601147614
|
Drug-Induced Abnormalities
|
Congenital Disorders of Glycosylation
|
0.15364182357778045
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.